Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients.

Yasuji Arase; Akihito Tsubota; Satoshi Saitoh; Yoshiyuki Suzuki; Masahiro Kobayashi; Fumitaka Suzuki; Takashi Someya; Norio Akuta; Kenji Ikeda; Mariko Kobayashi

doi:10.1016/s1386-6346(01)00169-3

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients.

NobleID: NI3P38W47R83S27
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CF744D91

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF744D91.svg?ark=w1%2F20260515%2FCF744D91&value=id)](https://nobleid.org/work/w1/20260515/CF744D91)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients.

NobleID: NI3P38W47R83S27
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CF744D91

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF744D91.svg?ark=w1%2F20260515%2FCF744D91&value=id)](https://nobleid.org/work/w1/20260515/CF744D91)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work